Document Detail


Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein.
MedLine Citation:
PMID:  12445429     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND/AIMS: Epidemiological studies have shown that coinfection or superinfection with hepatitis B virus (HBV) and C virus (HCV) frequently leads to the suppression of hepatitis B virus replication. The mechanism of this phenomenon is still unclear. Shih et al. [J Virol 1993;67:5823] reported a direct suppression of HBV replication by the core protein of HCV. The target structure of HCV core protein in this system remained unclear. METHODS: As HCV core protein has been shown to influence expression from transcriptional elements, we studied whether HCV core protein altered the activity of the two HBV enhancers 1 and 2. Luciferase vectors for HBV enhancers 1 or 2 were cotransfected with expression constructs for HCV core protein in murine and human hepatocyte lines. RESULTS: Full-length HCV core protein suppressed the HBV enhancer 1 up to 11-fold, the enhancer 2 3-4-fold. Suppression of HBV enhancer 1 by HCV core from genotype 1b was stronger than by HCV core of genotypes 3a or 1a. Carboxyterminally truncated core proteins had lower or no suppression activity. CONCLUSIONS: These data suggest that HCV core protein may directly repress transcription of the HBV RNAs. This trans-repression may contribute to suppression of HBV replication in patients coinfected with both viruses.
Authors:
Christian G Schüttler; Nicola Fiedler; Katja Schmidt; Reinald Repp; Wolfram H Gerlich; Stephan Schaefer
Related Documents :
18158729 - The functional evaluation of dendritic cell vaccines based on different hepatitis c vir...
10066669 - Restricted isotypic antibody reactivity to hepatitis c virus synthetic peptides in immu...
10761559 - Mixed cryoglobulinemia in hepatitis c patients. germivic.
15308699 - Inhibition of hepatitis c virus-like particle binding to target cells by antiviral anti...
12098759 - Expression and characterization of hepatitis c virus e2 glycoprotein fused to hepatitis...
2460859 - Induction of anti-human immunodeficiency virus (hiv) neutralizing antibodies in rabbits...
9211549 - Opportunistic infections in pediatric hiv infection: a study of 74 autopsy cases from l...
24739909 - Utilization of free dental health care services provided to the perinatally infected hu...
11866219 - Vascular imaging and interventional procedures in hepatic cirrhosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hepatology     Volume:  37     ISSN:  0168-8278     ISO Abbreviation:  J. Hepatol.     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-11-26     Completed Date:  2003-06-11     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8503886     Medline TA:  J Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  855-62     Citation Subset:  IM    
Affiliation:
Institut für Medizinische Virologie Justus-Liebig-Universität, Frankfurter Strasse 107, D-35392 Giessen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Line
Enhancer Elements, Genetic / drug effects*
Genotype
Hepatitis B virus / genetics*,  metabolism*
Hepatocytes / metabolism
Humans
Mice
Peptide Fragments / pharmacology
Tumor Cells, Cultured
Viral Core Proteins / chemistry,  pharmacology*
Chemical
Reg. No./Substance:
0/Peptide Fragments; 0/Viral Core Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepati...
Next Document:  Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a ...